G01N30/72

POROUS MEMBRANE ENABLED MASS SPECTROMETRY CHARACTERIZATION OF MICROFLUIDIC DEVICES
20230049075 · 2023-02-16 ·

A system for sampling a liquid includes a sample fluid conduit including a membrane having pores. The membrane prevents the passage of the sample liquid through the pores at a first pressure of the sample liquid in the sample fluid conduit. A surface sampling capture probe has a distal end. The capture probe includes a solvent supply conduit and a solvent exhaust conduit. A solvent composition flowing at the distal end of the capture probe establishes a liquid junction with the membrane and establishes a second pressure within the liquid junction at the membrane. The second pressure is lower than the first pressure. Sample liquid will be drawn through the pores of the membrane by the second pressure at the liquid junction. A method for sampling a liquid and for performing chemical analysis on a liquid are also disclosed.

METHOD AND SYSTEM FOR THE IDENTIFICATION OF COMPOUNDS IN COMPLEX BIOLOGICAL OR ENVIRONMENTAL SAMPLES

Method and system for the identification of compounds in complex biological or environmental samples by receiving (102) a mass spectrum (1) from a mass spectrometry coupled with a separation technique; for each data point (2) of the mass spectrum (1), annotating (106) in an annotation database (12) combinations of formulas and adducts the theoretical mass-to-charge ratio of which (m/z).sup.T corresponds to the mass-to-charge ratio (m/z) measured of the data point (2); for each formula and adduct annotated, detecting (108) regions of interest in a retention time range (RT.sub.0-RT.sub.1) according to characterisation criteria; generating (110) an inclusion list (14) with the retention time ranges (RT.sub.0-RT.sub.1) and the theoretical mass-to-charge ratios (m/z).sup.T of the formulas and adducts associated with the regions of interest; and sending (112) the inclusion list to a mass spectrometer for the identification of compounds in the sample by tandem mass spectrometry.

METHOD AND SYSTEM FOR THE IDENTIFICATION OF COMPOUNDS IN COMPLEX BIOLOGICAL OR ENVIRONMENTAL SAMPLES

Method and system for the identification of compounds in complex biological or environmental samples by receiving (102) a mass spectrum (1) from a mass spectrometry coupled with a separation technique; for each data point (2) of the mass spectrum (1), annotating (106) in an annotation database (12) combinations of formulas and adducts the theoretical mass-to-charge ratio of which (m/z).sup.T corresponds to the mass-to-charge ratio (m/z) measured of the data point (2); for each formula and adduct annotated, detecting (108) regions of interest in a retention time range (RT.sub.0-RT.sub.1) according to characterisation criteria; generating (110) an inclusion list (14) with the retention time ranges (RT.sub.0-RT.sub.1) and the theoretical mass-to-charge ratios (m/z).sup.T of the formulas and adducts associated with the regions of interest; and sending (112) the inclusion list to a mass spectrometer for the identification of compounds in the sample by tandem mass spectrometry.

MEDICAL DEVICE, THERAPEUTIC METHOD, AND DIAGNOSTIC METHODS FOR THE TREATMENT AND PREVENTION OF VASOSPASM
20230047766 · 2023-02-16 ·

A method for treating vasospasm may include measuring cerebrospinal fluid (CSF) to obtain a baseline biomarker value. The method may include administering a first dose of a trehalose solution. The method may include draining the CSF to maintain a current intracranial pressure (ICP). The method may include measuring a trehalose concentration in the CSF. The method may include measuring a biomarker value in the CSF. The method may end based on a determination that the measured biomarker value indicates a predetermined biomarker concentration.

MEDICAL DEVICE, THERAPEUTIC METHOD, AND DIAGNOSTIC METHODS FOR THE TREATMENT AND PREVENTION OF VASOSPASM
20230047766 · 2023-02-16 ·

A method for treating vasospasm may include measuring cerebrospinal fluid (CSF) to obtain a baseline biomarker value. The method may include administering a first dose of a trehalose solution. The method may include draining the CSF to maintain a current intracranial pressure (ICP). The method may include measuring a trehalose concentration in the CSF. The method may include measuring a biomarker value in the CSF. The method may end based on a determination that the measured biomarker value indicates a predetermined biomarker concentration.

Quantitative analysis method for monomer of photoresist binder
11579126 · 2023-02-14 · ·

A quantitative analysis method for a monomer of a color filter (CF) photoresist (PR) binder for a thin film transistor-liquid crystal display (TFT-LCD), performs quantitative analysis on a monomer of a CF PR binder for a RFT-LCD by using a Py-GC/MS used for qualitative analysis.

Quantitative analysis method for monomer of photoresist binder
11579126 · 2023-02-14 · ·

A quantitative analysis method for a monomer of a color filter (CF) photoresist (PR) binder for a thin film transistor-liquid crystal display (TFT-LCD), performs quantitative analysis on a monomer of a CF PR binder for a RFT-LCD by using a Py-GC/MS used for qualitative analysis.

Real-time peak detection

Techniques for real-time or substantially real-time peak detection are described. In one embodiment, for example, logic coupled to memory may be configured to receive data from at least one analytical instrument and perform processing or analysis on the received data. Moreover, the logic may be configured to determine, via one or more GPUs or CPUs (or both), one or more peaks based on the processing or the analysis of the received data and generate peak detection data based on the detected one or more peaks in real-time or substantially real-time. Other embodiments are described.

Method of simultaneous modeling and complexity reduction of bio-crudes for process simulation

The present invention relates to a method for reducing the complexity of bio-crudes. The method includes (a) obtaining experimental data of quantitative and qualitative analyses for the bio-crudes, (b) grouping compounds contained in the bio-crudes according to a predetermined basis based on the experimental data, (c) selecting representative compounds from among the compounds belonging to the same group, and (d) reconstituting the bio-crudes as a mixture of the representative compounds.

Anomaly detection of gas flow parameters in mass spectrometry

A mass spectrometry (MS) apparatus is provided. The MS apparatus includes a mass spectrometer, an ionization source coupled to the mass spectrometer, and a flow injection system (FIS) coupled to the ionization source. The ionization source is configured to provide an ionized gas flow of an analyte towards an entrance of the mass spectrometer. The ionization source is further configured to provide a second gas flow of a second gas. The MS apparatus is configured to measure a mass spectrometer (MS) signal of the analyte. The MS apparatus is further configured to analyze a dependency of the MS signal of the analyte versus a parameter of the second gas flow or a state of the second gas flow and to determine a condition of the apparatus based on the analyzed dependency.